trending Market Intelligence /marketintelligence/en/news-insights/trending/vEczJjaWSWD5NGoJr01qMw2 content esgSubNav
In This List

Recro Pharma plans to sell $40M of common stock

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise

Blog

Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises


Recro Pharma plans to sell $40M of common stock

Recro Pharma, Inc. plans to sell up to $40 million of its common shares from time to time.

Cowen and Co. LLC will act as the placement agent for the offering.